Adverse events in patients receiving cholinesterase inhibitors due to dissimilar follow-up periods.
Chan
Mark
M
D000544:Alzheimer Disease / Q000188:drug therapy; D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003704:Dementia / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D012107:Research Design; D013575:Syncope / Q000139:chemically induced*
D002800:Cholinesterase Inhibitors